RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

The options and planned restricted stock units vest over time, subject to the employees continuing their service.

Rhea-AI Summary

RxSight (RXST) granted inducement stock options covering 236,456 common shares to two new non-executive officer employees as they began employment.

The options were granted on October 23, 2026, with an exercise price of $5.02 per share, equal to the closing share price that day. RxSight also agreed to grant the same employees restricted stock units (RSUs), awards covering 637,449 common shares, anticipated on or about November 3, 2026. The awards fall under the 2026 Inducement Equity Incentive Plan and Nasdaq Listing Rule 5635(c)(4).

Positive

• None.

Negative

• Minor point236,456 shares underlying granted options at a $5.02 exercise price represent potential dilution.
• Minor point. Forward-looking: it has not happened yet and may not happen.637,449 shares underlying planned RSUs, anticipated on or about November 3, 2026, represent potential dilution.

News Explained

The options vest subject to continued service, with 25% on the one-year anniversary of October 23, 2026 and one forty-eighth monthly thereafter; the agreed RSUs are also service-conditioned and vest in six installments from February 28, 2027 through August 31, 2029.

Key Figures

Inducement stock options: 236,456 shares Inducement RSUs: 637,449 shares Option exercise price: $5.02 per share +2 more

Inducement stock options

236,456 shares

Granted to two new non-executive employees

Inducement RSUs

637,449 shares

Agreed for the same employees; anticipated grant on or about November 3, 2026

Option exercise price

$5.02 per share

Equal to the closing price on the October 23, 2026 grant date

Option vesting

25% after one year; 1/48 monthly thereafter

Subject to continuing service

RSU vesting

1/6 on each of six scheduled vesting dates

February 28, 2027; August 31, 2027; February 29, 2028; August 31, 2028; February 28, 2029; August 31, 2029

Key Terms

restricted stock units, nasdaq listing rule 5635(c)(4)

2 terms

restricted stock units financial

"inducement restricted stock units (RSUs) covering a total of 637,449 shares"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

nasdaq listing rule 5635(c)(4) regulatory

"in accordance with Nasdaq Listing Rule 5635(c)(4)"

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ALISO VIEJO, Calif., Oct. 23, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced that on October 23, 2026, RxSight granted inducement stock options to purchase a total of 236,456 shares of RxSight’s common stock to two new non-executive officer employees in connection with the commencement of their employment with RxSight. RxSight also agreed to grant inducement restricted stock units (RSUs) covering a total of 637,449 shares of RxSight’s common stock to the same employees in connection with the commencement of their employment with RxSight, which RSUs are anticipated to be granted on or about November 3, 2026.

Each inducement stock option has an exercise price of $5.02 per share, which is equal to the closing price of a share of RxSight common stock on the grant date, and shall vest as follows, subject to continuing service: 25% of the shares subject to such inducement stock option shall vest on the one year anniversary of October 23, 2026, and one forty-eighth (1/48th) of the shares subject to such inducement stock option shall vest monthly thereafter.

Each inducement RSU award shall vest as follows, subject to continuing service: one-sixth of the shares subject to the inducement RSU award shall vest on the first trading day on or after each of February 28, 2027, August 31, 2027, February 29, 2028, August 31, 2028, February 28, 2029, and August 31, 2029.

Each inducement award is subject to the terms of the RxSight, Inc. 2026 Inducement Equity Incentive Plan and related forms of agreements, and were granted as inducements material to these employees to enter into employment with RxSight in accordance with Nasdaq Listing Rule 5635(c)(4).

About RxSight, Inc.

RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The Light Adjustable Lens™ system, comprised of the RxSight Light Adjustable Lens™ products (LAL™ and LAL+™), RxSight Light Delivery Device™ (LDD™), and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.

Light Adjustable Lens™, LAL™, LAL+™, Light Delivery Device™ and LDD™ are trademarks of RxSight, Inc.

Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How do RxSight's October 2026 inducement stock options vest?

The options vest 25% on the one-year anniversary of October 23, 2026, followed by one forty-eighth (1/48th) of the shares monthly thereafter. Vesting is subject to continuing service.

When will RxSight's planned inducement RSUs vest?

The planned RSUs vest in one-sixth installments on the first trading day on or after each of February 28, 2027, August 31, 2027, February 29, 2028, August 31, 2028, February 28, 2029, and August 31, 2029. Vesting is subject to continuing service.